| Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ... EBioMedicine 38, 100-112, 2018 | 183 | 2018 |
| GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma AA El-Arabey, M Denizli, P Kanlikilicer, R Bayraktar, C Ivan, M Rashed, ... Cellular signalling 68, 109539, 2020 | 94 | 2020 |
| Therapeutic targeting of AXL receptor tyrosine kinase inhibits tumor growth and intraperitoneal metastasis in ovarian cancer models P Kanlikilicer, B Ozpolat, B Aslan, R Bayraktar, N Gurbuz, ... Molecular Therapy-Nucleic Acids 9, 251-262, 2017 | 63 | 2017 |
| Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs MH Rashed, P Kanlikilicer, C Rodriguez-Aguayo, M Pichler, R Bayraktar, ... Oncotarget 8 (12), 20145, 2017 | 62 | 2017 |
| Maternal obesity and the impact of associated early-life inflammation on long-term health of offspring M Denizli, ML Capitano, KL Kua Frontiers in cellular and infection microbiology 12, 940937, 2022 | 30 | 2022 |
| Chitosan nanoparticles for miRNA delivery M Denizli, B Aslan, LS Mangala, D Jiang, C Rodriguez-Aguayo, ... RNA Nanostructures: Methods and Protocols, 219-230, 2017 | 22 | 2017 |
| Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine. 2018; 38: 100–12 P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ... Epub 2018/11/30. https://doi. org/10.1016/j. ebiom. 2018.11. 004 PMID: 30487062, 0 | 9 | |
| Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’[EBioMedicine 38 (2018) 100–112] P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ... EBioMedicine 52, 2020 | 6 | 2020 |
| CORRIGENDUM: GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma (Cellular Signalling (2020) 68 … AA El-Arabey, M Denizli, P Kanlikilicer, R Bayraktar, C Ivan, M Rashed, ... Cellular Signalling 89, 110147, 2022 | 3 | 2022 |
| Maternal Obesity Causes Sex Specific Long-Term Hematopoietic and Metabolic Defects M Denizli, J Ropa, L Beasley, K DeVanna, LS Haneline, KL Kua, ... Blood 142, 31, 2023 | | 2023 |
| Maternal obesity and the impact of associated early-life inflammation on long-term health of offspring M Denizli, ML Capitano, KL Kua Frontiers in Cellular and Infection Microbiology 12, 940937, 2022 | | 2022 |
| GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma (vol 68, 109539, 2020) AA El-Arabey, M Denizli, P Kanlikilicer, R Bayraktar, C Ivan, M Rashed, ... CELLULAR SIGNALLING 89, 2022 | | 2022 |
| M2-macrophage derived exosomes mediates tumor progression via GATA3-IL-4-IL-13 axis in ovarian cancer P Kanlikilicer, AA El-Arabey, M Denizli, R Bayraktar, B Ozpolat, ... Cancer Research 79 (13_Supplement), 1981-1981, 2019 | | 2019 |
